SecBot SecBot
SECBOTREPLAY Home › Report › SNDX

SNDX · CFO files Form 3

Syndax Pharmaceuticals Inc · 3 filed Nov 12, 2026 at 16:00 ET

At the news

NEUTRALIMPACT 1/10

3 filed Nov 12, 2026 at 16:00 ET

Aaron Ondrey filed a Form 3 initial statement of beneficial ownership after becoming Chief Financial Officer of Syndax Pharmaceuticals. The filing reports no securities owned and is a routine compliance document with no trading or financial impact.

  • Aaron Ondrey appointed Chief Financial Officer of Syndax Pharmaceuticals Inc.
  • Form 3 filed on 2026-11-12, reporting period 2026-11-09.
  • No securities ownership reported in the filing.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access